共 50 条
Cost-effectiveness of Anticipatory and Preventive multidisciplinary Team Care for complex patients Evidence from a randomized controlled trial
被引:0
|作者:
Gray, David
[2
]
Armstrong, Catherine Deri
[2
,4
]
Dahrouge, Simone
[1
]
Hogg, William
[3
]
Zhang, Wei
[5
]
机构:
[1] Univ Ottawa, Dept Family Med, Elisabeth Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON K1N 5C8, Canada
[2] Univ Ottawa, Dept Econ, Ottawa, ON K1N 6N5, Canada
[3] Univ Ottawa, Dept Family Med, Ottawa, ON K1N 6N5, Canada
[4] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada
[5] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
关键词:
COGNITIVE-BEHAVIORAL THERAPY;
D O I:
暂无
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
OBJECTIVE To evaluate the cost-effectiveness of Anticipatory and Preventive Team Care (APTCare). DESIGN Analysis of data drawn from a randomized controlled trial. SETTING A family health network in a rural area near Ottawa, Ont. PARTICIPANTS Patients 50 years of age or older at risk of experiencing adverse health outcomes. Analysis of cost-effectiveness was performed for a subsample of participants with at least 1 of the chronic diseases used in the quality of care (QOC) measure ( 74 intervention and 78 control patients). INTERVENTIONS At-risk patients were randomly assigned to receive usual care from their family physicians or APTCare from a collaborative team. MAIN OUTCOME MEASURES Cost-effectiveness and the net benefit to society of the APTCare intervention. RESULTS Costs not directly associated with delivery of the intervention were similar in the 2 arms: $9121 and $9222 for the APTCare and control arms, respectively. Costs directly associated with the program were $3802 per patient for a total cost per patient of $12 923 and $9222, respectively (P=.033). A 1% improvement in QOC was estimated to cost $407 per patient. Analysis of the net benefit to society in absolute dollars found a break-even threshold of $750 when statistical significance was required. This implies that society must place a value of at least $750 on a 1% improvement in QOC in order for the intervention to be socially worthwhile. By any of the metrics used, the APTCare intervention was not cost-effective, at least not in a population for which baseline QOC was high. CONCLUSION Although our calculations suggest that the APTCare intervention was not cost-effective, our results need the following caveats. The costs of such a newly introduced intervention are bound to be higher than those for an established, up-and-running program. Furthermore, it is possible that some benefits of the secondary preventive measures were not captured in this limited 12- to 18-month study or were simply not measured.
引用
收藏
页码:E20 / E29
页数:10
相关论文